Literature DB >> 10797176

Transcranial doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke.

W S Burgin1, M Malkoff, R A Felberg, A M Demchuk, I Christou, J C Grotta, A V Alexandrov.   

Abstract

BACKGROUND AND
PURPOSE: Transcranial Doppler (TCD) can demonstrate arterial occlusion and subsequent recanalization in acute ischemic stroke patients treated with intravenous tissue plasminogen activator (tPA). Limited data exist to assess the accuracy of recanalization by TCD criteria.
METHODS: In patients with acute middle cerebral artery (MCA) occlusion treated with intravenous tPA, we compared posttreatment TCD with angiography (digital subtraction or magnetic resonance). On TCD, complete occlusion was defined by absent or minimal signals, partial occlusion by blunted or dampened signals, and recanalization by normal or stenotic signals. Angiography was evaluated with the Thrombolysis In Myocardial Ischemia (TIMI) grading scale.
RESULTS: Twenty-five patients were studied (age 61+/-18 years, 16 men and 9 women). TCD was performed at 12+/-16 hours and angiography at 41+/-57 hours after stroke onset, with 52% of studies performed within 3 hours of each other. Recanalization on TCD had the following accuracy parameters compared with angiography: sensitivity 91%, specificity 93%, positive predictive value (PPV) 91%, and negative predictive value (NPV) 93%. To predict partial occlusion (TIMI grade II), TCD had sensitivity of 100%, specificity of 76%, PPV of 44%, and NPV of 100%. TCD predicted the presence of complete occlusion on angiography (TIMI grade 0 or I) with sensitivity of 50%, specificity of 100%, PPV of 100%, and NPV of 75%. TCD flow signals correlated with angiographic patency (chi(2)=24.2, P<0.001).
CONCLUSIONS: Complete MCA recanalization on TCD accurately predicts angiographic findings. Although a return to normal flow dynamics on TCD was associated with complete angiographic resumption of flow, partial signal improvement on TCD corresponded with persistent occlusion on angiography.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10797176     DOI: 10.1161/01.str.31.5.1128

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  22 in total

Review 1.  Role of transcranial Doppler ultrasonography in evaluation of patients with cerebrovascular disease.

Authors:  Vijay K Sharma; Georgios Tsivgoulis; Annabelle Y Lao; Andrei V Alexandrov
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

2.  Transcranial diffuse optical assessment of the microvascular reperfusion after thrombolysis for acute ischemic stroke.

Authors:  Raquel Delgado-Mederos; Clara Gregori-Pla; Peyman Zirak; Igor Blanco; Lavinia Dinia; Rebeca Marín; Turgut Durduran; Joan Martí-Fàbregas
Journal:  Biomed Opt Express       Date:  2018-02-21       Impact factor: 3.732

3.  Usefulness of ADAMTS13 to predict response to recanalization therapies in acute ischemic stroke.

Authors:  Alejandro Bustamante; MingMing Ning; Teresa García-Berrocoso; Anna Penalba; Cristina Boada; Alba Simats; Jorge Pagola; Marc Ribó; Carlos Molina; Eng Lo; Joan Montaner
Journal:  Neurology       Date:  2018-02-14       Impact factor: 9.910

4.  S100B as a surrogate marker for successful clot lysis in hyperacute middle cerebral artery occlusion.

Authors:  C Foerch; R du Mesnil de Rochemont; O Singer; T Neumann-Haefelin; M Buchkremer; F E Zanella; H Steinmetz; M Sitzer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-03       Impact factor: 10.154

Review 5.  Controversies about tissue plasminogen activator: extending the window of therapy.

Authors:  S C Orr; C R Gomez
Journal:  Curr Atheroscler Rep       Date:  2001-07       Impact factor: 5.113

6.  Plasmin-loaded echogenic liposomes for ultrasound-mediated thrombolysis.

Authors:  Madhuvanthi A Kandadai; Jason M Meunier; Kimberley Hart; Christy K Holland; George J Shaw
Journal:  Transl Stroke Res       Date:  2014-11-20       Impact factor: 6.829

7.  Individual lytic efficacy of recombinant tissue plasminogen activator in an in vitro human clot model: rate of "nonresponse".

Authors:  Jason M Meunier; Evan Wenker; Christopher J Lindsell; George J Shaw
Journal:  Acad Emerg Med       Date:  2013-05       Impact factor: 3.451

8.  Microfluidic manufacture of rt-PA -loaded echogenic liposomes.

Authors:  Madhuvanthi A Kandadai; Prithviraj Mukherjee; Himanshu Shekhar; George J Shaw; Ian Papautsky; Christy K Holland
Journal:  Biomed Microdevices       Date:  2016-06       Impact factor: 2.838

9.  Neuroendovascular Rescue: Interventional Treatment of Acute Ischemic Stroke.

Authors:  Camilo R. Gomez; Sean C. Orr; Rodney D. Soto
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-10

10.  Factors related to progression of middle cerebral artery stenosis determined using transcranial Doppler ultrasonograhy.

Authors:  Hyung-Won Jeon; Jae-Kwan Cha
Journal:  J Thromb Thrombolysis       Date:  2007-06-01       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.